Invention Grant
- Patent Title: Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
- Patent Title (中): 用抗内酯或内酯衍生的信号分子抗体治疗感染性细菌性疾病的方法
-
Application No.: US12791927Application Date: 2010-06-02
-
Publication No.: US08168397B2Publication Date: 2012-05-01
- Inventor: Keith Alan Charlton , Andrew Justin Radcliffe Porter
- Applicant: Keith Alan Charlton , Andrew Justin Radcliffe Porter
- Applicant Address: GB Aberdeen
- Assignee: Haptogen Ltd.
- Current Assignee: Haptogen Ltd.
- Current Assignee Address: GB Aberdeen
- Agency: Pfizer Inc.
- Agent John L. Miller; Raquel M. Alvarez
- Priority: GB0218951.2 20020813; GB0306783.2 20030324
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/554

Abstract:
The present invention relates to methods for the control of virulence of infectious bacteria by modulating the extra-cellular concentration of bacterial cell signalling molecules. Derivatives of cell signalling molecules are conjugated to suitable carrier proteins and used to isolate high affinity receptors recognizing the native signal molecule(s). By binding to signalling molecules, the receptors reduce and maintain extra-cellular concentrations of signal molecules below the threshold level that would otherwise result in certain opportunistic pathogens adopting a virulent form, and can transform virulent organisms to non-virulent states. These receptors have applications for the treatment of individuals with susceptibility to infection, the treatment of patients with existing infections, in disease monitoring and management, and in related applications where the host for infection is an animal or plant.
Public/Granted literature
Information query
IPC分类: